OMass Therapeutics raised €90M in a Series B round in Apr 2022. The company is based in Oxford, UK. Investors in the round: GV, Northpond Ventures, Oxford Science Enterprises and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
